Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 323

1.

Integrating primary medical care with addiction treatment: a randomized controlled trial.

Weisner C, Mertens J, Parthasarathy S, Moore C, Lu Y.

JAMA. 2001 Oct 10;286(14):1715-23.

2.

Utilization and cost impact of integrating substance abuse treatment and primary care.

Parthasarathy S, Mertens J, Moore C, Weisner C.

Med Care. 2003 Mar;41(3):357-67.

PMID:
12618639
3.

The outcome and cost of alcohol and drug treatment in an HMO: day hospital versus traditional outpatient regimens.

Weisner C, Mertens J, Parthasarathy S, Moore C, Hunkeler EM, Hu T, Selby JV.

Health Serv Res. 2000 Oct;35(4):791-812.

4.

Costs and effectiveness of substance abuse treatments for homeless persons.

Schumacher JE, Mennemeyer ST, Milby JB, Wallace D, Nolan K.

J Ment Health Policy Econ. 2002 Mar;5(1):33-42.

PMID:
12529568
5.

Effect of primary medical care on addiction and medical severity in substance abuse treatment programs.

Friedmann PD, Zhang Z, Hendrickson J, Stein MD, Gerstein DR.

J Gen Intern Med. 2003 Jan;18(1):1-8.

6.

The role of medical conditions and primary care services in 5-year substance use outcomes among chemical dependency treatment patients.

Mertens JR, Flisher AJ, Satre DD, Weisner CM.

Drug Alcohol Depend. 2008 Nov 1;98(1-2):45-53. doi: 10.1016/j.drugalcdep.2008.04.007. Epub 2008 Jun 20.

7.

Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.

Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Uldall KK, Ettner SL.

J Ment Health Policy Econ. 2009 Mar;12(1):33-46.

PMID:
19346565
8.
9.

Randomized trial of onsite versus referral primary medical care for veterans in addictions treatment.

Saxon AJ, Malte CA, Sloan KL, Baer JS, Calsyn DA, Nichol P, Chapko MK, Kivlahan DR.

Med Care. 2006 Apr;44(4):334-42.

PMID:
16565634
10.

Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample.

Parthasarathy S, Weisner CM.

Drug Alcohol Depend. 2005 Nov 1;80(2):231-40.

PMID:
15916868
11.

Managing psychiatric comorbidity within versus outside of methadone treatment settings: a randomized and controlled evaluation.

Brooner RK, Kidorf MS, King VL, Peirce J, Neufeld K, Stoller K, Kolodner K.

Addiction. 2013 Nov;108(11):1942-51. doi: 10.1111/add.12269. Epub 2013 Jul 19.

12.

Individuals receiving addiction treatment: are medical costs of their family members reduced?

Weisner C, Parthasarathy S, Moore C, Mertens JR.

Addiction. 2010 Jul;105(7):1226-34. doi: 10.1111/j.1360-0443.2010.02947.x. Epub 2010 May 14.

13.

Organizational and client determinants of cost in outpatient substance abuse treatment.

Beaston-Blaakman A, Shepard D, Horgan C, Ritter G.

J Ment Health Policy Econ. 2007 Mar;10(1):3-13.

PMID:
17417043
14.
15.

Association of outpatient alcohol and drug treatment with health care utilization and cost: revisiting the offset hypothesis.

Parthasarathy S, Weisner C, Hu TW, Moore C.

J Stud Alcohol. 2001 Jan;62(1):89-97.

PMID:
11271969
16.

Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?

Ettner SL, Huang D, Evans E, Ash DR, Hardy M, Jourabchi M, Hser YI.

Health Serv Res. 2006 Feb;41(1):192-213. Erratum in: Health Serv Res. 2006 Apr;41(2):613.

17.
18.

Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.

Peirce JM, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, Schwartz M, Krasnansky J, Pencer E, Silva-Vazquez L, Kirby KC, Royer-Malvestuto C, Roll JM, Cohen A, Copersino ML, Kolodner K, Li R.

Arch Gen Psychiatry. 2006 Feb;63(2):201-8.

PMID:
16461864
19.
20.

Training the next generation of providers in addiction medicine.

Rasyidi E, Wilkins JN, Danovitch I.

Psychiatr Clin North Am. 2012 Jun;35(2):461-80. doi: 10.1016/j.psc.2012.04.001.

PMID:
22640766
Items per page

Supplemental Content

Write to the Help Desk